Navigation Links
Glaxo Official Memo Urged Scientists to Withhold Information About Paxil's Risks, Trial Hears; Pharmaceutical Industry Today Offers Complete News Coverage
Date:9/16/2009

WASHINGTON, Sept. 16 /PRNewswire-USNewswire/ -- Antidepressant drug Paxil, which generated about 2.1% of GlaxoSmithKline's total revenue last year, has been known to cause birth defects, but the world's second-biggest drugmaker hid its risks to pump up profits, a Philadelphia court has heard.

According to available information, Glaxo failed to properly test the drug and urged scientists to conceal Paxil's risks. The Philadelphia trial is the first of more than 600 cases against the London-based company.

Are you satisfied with the way your regular news sources report on these important stories? If not, try Pharmaceutical Industry Today (http://pharmaceuticals.einnews.com/), for free, to see what you may have been missing.

See:

-- GlaxoSmithKline News - http://pharmaceuticals.einnews.com/news/glaxosmithkline

-- Paxil News - http://pharmaceuticals.einnews.com/news/paxil

-- Latest Pharmaceutical News - http://pharmaceuticals.einnews.com/

For a free trial to Pharmaceutical Industry Today, go to: http://pharmaceuticals.einnews.com/users/register.php

About the publisher of Pharmaceutical Industry Today, EIN News, http://www.einnews.com/

EIN News was established in 1995, and through the years has built more than 200,000 news feeds organized within over 80 individual news sites. The company has launched the well-known 'Russia News Service' brand and opened Internet news access to China with 'Inside China Today'.

Offering a unique combination of human editing and proprietary scanning software, EIN News won Europe's coveted Momentum Award as the most innovative internet company on the continent. Serving millions of customers, the company distributes its feeds via email or mobile news alerts, online and other channels such as Newsfeed Maker (http://www.newsfeedmaker.com/) and EIN Presswire (http://www.einpresswire.com/).


'/>"/>
SOURCE EIN News
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. By 2018, GlaxoSmithKlines Votrient Will Garner Sales of $640 Million and Will Overtake Pfizers Sutent as the Renal Cell Carcinoma Market Leader
2. GlaxoSmithKline Statement Confirming alli Safety
3. Mahindra Satyam Signs 5 Year SAP Contract with GlaxoSmithKline
4. GlaxoSmithKline 13th Annual IMPACT Awards Seek Nonprofits Providing Access to Healthcare
5. GlaxoSmithKline Opens $600million Vaccine Plant In Singapore
6. GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands
7. GlaxoSmithKline Travel Health: 55 percent of travellers needlessly put themselves at risk from a potentially fatal virus
8. Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009
9. GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million
10. GlaxoSmithKline Update: Influenza A (H1N1)
11. GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... ... Cal Dining at the University of California Berkeley, and other leading institutions in ... the buying power of institutions to change the way animals are raised for ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology: